Aurinia Pharmaceuticals Inc (AUPH)

EBITDA

$54.57M

Quarterly · Period ending: · USD

AUPH logo

AUPH EBITDA

Latest reported$54.57M
AUPH Quarterly EBITDA (-$132.58K → $54.57M)
High-resolution chart · PNG

AUPH ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-2,236,149
-2,504,648
-1,426,476
-1,668,502
-758,067
-483,370
-911
-405,391
-132,582
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.